
ScienceLink
by ScienceLink
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇨🇴CO · Medicine#112500 to 3K
- 🇵🇪PE · Medicine#119500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
500 to 3K🎙 ~2x weekly·713 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
1K to 6K🇨🇴50%🇵🇪50% - Active Followers
Loyal subscribers who consistently listen
300 to 1.8K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 29 epsHosts
Recent guests
Recent episodes
Tumores Cerebrales
Jul 13, 2026
20m 00s
Chicago 2026: Lo más destacado en Cáncer de Mama
Jul 9, 2026
33m 41s
Chicago 2026: Lo más destacado en Tumores Ginecológicos
Jul 8, 2026
19m 54s
Chicago 2026: Lo más destacado en Tumores Genitourinarios
Jul 6, 2026
19m 20s
Chicago 2026: Lo más destacado en Sarcomas
Jul 1, 2026
28m 37s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/13/26 | tumores cerebralesneurooncología+4 | Dra. Ytel Garcilazo | isocitrato deshidrogenasaCDKN2A/B+7 | — | tumores cerebralesneurooncología+5 | — | 20m 00s | ||
| 7/9/26 | cáncer de mamamedicina personalizada+4 | Dr. Antonio LlombartDr. Fernando Petracci | Sociedad Americana de Oncología ClínicaHospital Arnau de Vilanova+3 | — | cáncer de mamamedicina personalizada+5 | — | 33m 41s | ||
| 7/8/26 | tumores ginecológicosoncología+3 | Dra. Laura VenegasDr. Eduardo González | mirvetuximabchiauranib+12 | — | tumores ginecológicoscáncer de ovario+3 | — | 19m 54s | ||
| 7/6/26 | urooncologíacáncer de próstata+3 | Dr. Augusto Ferreyra | Instituto Nacional de CancerologíaHospital Universitario Austral+1 | — | tumores genitourinarioscáncer de próstata+6 | — | 19m 20s | ||
| 7/1/26 | sarcomasoncology+3 | Dr. Javier Martín Broto | abemaciclibozekibart+6 | — | sarcomasoncology+8 | — | 28m 37s | ||
| 6/29/26 | oncología gastrointestinalcáncer de páncreas+4 | Dr. Diego Felipe Ballén | Instituto Nacional de CancerologíaSociedad Americana de Oncología Clínica+3 | Bogotá, ColombiaChicago | tumores gastrointestinalescáncer de páncreas metastásico+5 | — | 35m 45s | ||
| 6/26/26 | melanomaoncology+4 | Dra. Teresa Puértolas | daromuncamrelizumab+8 | — | melanomaoncology+3 | — | 20m 40s | ||
| 6/24/26 | cancer treatmentlung cancer+4 | Dr. Claudio Martín | selpercatiniblorlatinib+6 | — | lung canceroncology+6 | — | 46m 43s | ||
| 6/22/26 | cáncer de mamaoncología médica+4 | Dr. Denis Landaverde | giredestranteverolimus+4 | — | cáncer de mamagiredestrant+6 | — | 38m 06s | ||
| 6/19/26 | cáncer gástricomedicina paliativa+3 | Dra. Ana Lucía Domínguez Franco | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán | — | cáncer gástricomedicina paliativa+3 | — | 42m 33s | ||
| 6/9/26 | Linfoma FolicularInmunoterapia+4 | Dra. Anna Sureda | Institut Català d’Oncologia | l’Hospitalet, Barcelona | linfoma folicularinmunoterapia+6 | — | 17m 47s | ||
| 6/3/26 | cancer treatmentoncology+3 | Dra. Alejandra Martínez | Centro Médico ABCClínica de Cáncer de Mama y Tumores Ginecológicos del Instituto Nacional de Ciencias Médicas y Nutrición+4 | — | canceroncology+7 | — | 35m 27s | ||
| 6/2/26 | oncologyprostate cancer+4 | Dr. Salvador Víctor | Hospital General de MéxicoInstituto Nacional de Perinatología+6 | — | oncologyprostate cancer+5 | — | 28m 33s | ||
| 6/1/26 | oncologyclinical trials+4 | Dra. Mónica Meneses | daraxonrasibselpercatinib+6 | — | oncologyclinical trials+7 | — | 34m 58s | ||
| 5/31/26 | oncologyclinical trials+4 | Dr. Fabián MartínezDr. Raúl Mellado Orellana | giredestrantsunvozertinib+9 | Chicago, IL | oncologyclinical trials+8 | — | 38m 19s | ||
| 5/30/26 | esclerosis múltipleneurología+4 | Dra. Lizeth Zertuche | Centro Médico NavalHospital Ángeles Pedregal | — | esclerosis múltipleneurología cognitiva+4 | — | 18m 56s | ||
| 4/30/26 | Parkinson's diseaseneurology+3 | Dr. Óscar Esquivel | Instituto Nacional de Neurología y NeurocirugíaMovement Disorder Society | Ciudad de México | Parkinson's diseaseneurology+5 | — | 21m 20s | ||
| 4/30/26 | linfomaterapia CAR-T+3 | Dra. Anna Sureda | CAR-Tepcoritamab+1 | — | linfomaCAR-T+5 | — | 27m 15s | ||
| 4/24/26 | cancer researchhormonal therapy+4 | Dr. Miguel MartínDr. Manuel Ruiz Borrego | Grupo Español de Investigación en Cáncer de Mama (GEICAM)Universidad Complutense de Madrid | Hospital Gregorio MarañónMadrid+2 | lidERAgiredestrant+6 | — | 31m 50s | ||
| 4/15/26 | oncologyuncertainty+2 | Dr Sergio Cifuentes | The Power of “I Don’t Know” | MedellínColombia | oncology practiceshared decision-making+2 | — | 36m 17s | ||
| 3/26/26 | tumores neuroendocrinossíndrome carcinoide cardíaco+3 | Dr José Patricio López | ACHO TNE: entre la evidencia y la prácticaACHO Tumores Neuroendocrinos: entre la evidencia y la práctica | Colombia | biomarcadoresNT-proBNP+3 | — | 15m 37s | ||
| 3/23/26 | oncologygenitourinary tumors+1 | Dr Ovidio Fernández | ASCO®ASCO GU™+9 | San FranciscoGalicia+2 | prostate cancerbladder cancer+2 | — | 24m 10s | ||
| 3/18/26 | cáncer colorrectaloncología+3 | Dr Emilio Conde Flores | pruebas de sangre oculta en hecesScienceLink | México | epidemiologíadiagnóstico+2 | — | 24m 28s | ||
| 3/13/26 | canceroncology+2 | Dra Sandra FrancoDra Valeria Cáceres+1 | BreastLinkABC8+1 | América LatinaBuenos Aires+5 | CDK4/6 inhibitorsADC+2 | — | 52m 26s | ||
| 3/10/26 | hemofiliacoagulopatías+2 | Dr Mauricio Jaramillo Restrepo | emicizumabla Universidad de Antioquia+3 | — | enfermedad huérfanadeficiencia de factores de coagulación+2 | — | 17m 13s |
Showing 25 of 25
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for ScienceLink
Peaked at #112 in CO, currently #112 in CO.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| CO | — | #112 | #112 | — |
| PE | — | #119 | #119 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.